Log in
Enquire now
Aimmune Therapeutics

Aimmune Therapeutics

Aimmune Therapeutics is a food allergy therapies founded in 2011 by Bryan Walser.

OverviewStructured DataIssuesContributors

Contents

aimmune.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Biomedical engineering
Biomedical engineering
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Healthcare
Healthcare
Therapeutics
Therapeutics
...
Location
Bridgewater Township, New Jersey
Bridgewater Township, New Jersey
0
New Jersey
New Jersey
Brisbane, California
Brisbane, California
0
Dublin
Dublin
0
London
London
0
Durham, North Carolina
Durham, North Carolina
0
Münchenbernsdorf
Münchenbernsdorf
0
San Francisco
San Francisco
B2X
B2B
B2B
0
CEO
‌
Andrew Oxtoby
0
Founder
Bryan Walser
Bryan Walser
Pitchbook URL
pitchbook.com/profiles.../57690-10
Legal Name
Aimmune Therapeutics, Inc.
Number of Employees (Ranges)
501 – 1,0000
Email Address
media@aimmune.com
corporatedevelopment@aimmune.com0
hr@aimmune.com
Phone Number
+4420862902400
+49152584653010
+165061452200
+191986426430
+353189349570
Number of Employees
3390
Full Address
Mies-van-der-Rohe-Straße 6 80807 München0
8000 Marina Boulevard Suite 300 Brisbane, CA 94005-18840
1041 US-202 Bridgewater Township, NJ 088070
1005 Slater Road Suite 300 Durham, NC 277030
Block B The Crescent Building Northwood, Santry, Dublin 9 Dublin D09 C6X8 Republic of Ireland0
10 Eastbourne Terrace London W2 6LG0
CIK Number
1,631,6500
Place of Incorporation
Delaware
Delaware
0
Investors
Nestlé Health Science
Nestlé Health Science
Longitude Capital
Longitude Capital
Foresite Capital
Foresite Capital
DUNS Number
0575627710
IRS Number
452,748,2440
Founded Date
2011
Total Funding Amount (USD)
97,000,000
Latest Funding Round Date
March 12, 2015
Competitors
Aclaris Therapeutics
Aclaris Therapeutics
BridgeBio
BridgeBio
Nivalis Therapeutics
Nivalis Therapeutics
Interius BioTherapeutics
Interius BioTherapeutics
Stock Symbol
AIMT
Exchange
Nasdaq
Nasdaq
Latest Funding Type
Series B
Series B
CAGE Code
8H6R20
Patents Assigned (Count)
10
Country
United States
United States
0
Germany
Germany
0
United Kingdom
United Kingdom
0
Republic of Ireland
Republic of Ireland
0
Headquarters
Brisbane, California
Brisbane, California
0

Other attributes

Acquirer
Nestle Health Science
Nestle Health Science
Company Operating Status
Active
Latest Funding Round Amount (USD)
80,000,000
Previous Name
Allergen Research Corp0
SIC Code
2,8340
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Aimmune Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.